1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Supplemental Table 1:Bivariate analysis of imaging and laboratory findings in patients with COVID-19 dichotomized by location at stroke onset
Variable Median (IQR) In-Hospital (No.) (%) Out-of-Hospital (No.) (%) P Value Patients (No.) 86 41 45 Age (yr) 20–69 years of age 68 (60–76) 20 (48.8) 26 (57.8) .403 Sex, male 26 (63.4) 22 (48.9) .176 Imaging Ischemic stroke 39 (95.1) 33 (73.3) .006 Infarction, no hemorrhage 26 (63.4) 31 (68.9) .001 Infarction with HT 5 (12.2) 1 (2.2) Infarction and ICH 8 (19.5) 1 (2.2) Pure ICH, no infarction 2 (4.9) 12 (26.8) Multivascular territory infarction (n = 72) 22 (56.4) 11 (33.3) .022 Deep vein thrombosis 12 (29.3) 1 (2.2) .001 Laboratory values White blood cella ≥10.5 K/uL 9.7 (7.2–14.7) 25 (61.0) 12 (26.7) .001 Lymphocytesb <1.00 K/uL 0.6 (0.31–1.05) 37 (90.2) 25 (55.6) .001 Hemoglobina <11.5 g/dL 12.3 (9.7–13.8) 19 (46.3) 16 (35.6) .309 Plateletsa <150 K/uL 247 (152–335) 9 (22.0) 10 (22.2) .976 aPTTa,c >36.3 seconds 30.9 (28.4–36.1) 13 (32.5) 7 (17.1) .108 INRa,c >1.20 1.17 (1.07–1.31) 19 (48.7) 17 (39.5) .403 D-dimer,c 4× nl >920 ng/mL 3060 (1064–24,211) 37 (92.5) 17 (54.8) .001 C-reactive protein,c 2× nl >10.0 mg/L 17.5 (6.4–28.8) 30 (79.0) 14 (43.8) .002 Ferritin,c 4× nl >1200 ng/mL 1382 (706–2424) 30 (79.0) 10 (31.1) <.001 LDH,c 2× nl >484 U/L 536 (357–815) 27 (73.0) 12 (42.9) .014 ALT,c 2× nl >90.0 U/L 50 (29–136) 32 (78.1) 17 (39.5) <.001 Creatininec >1.30 mg/dL 1.30 (0.93–2.81) 28 (70.0) 15 (34.1) .001
Note:—HT indicates hemorrhagic transformation; ICH, intracranial hemorrhage; nl, upper limit of the normal value; aPTT, activated partial thromboplastin time; INR, international normalized ratio; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; IQR, interquartile range.
↵a White blood cell count, hemoglobin, platelets, activated aPTT, and INR are from admission or at the time of consultation for stroke. Remaining laboratory values (except lymphocyte count) are the maximum level during the hospitalization.
↵b Lowest lymphocyte count during admission.
↵c Variable has missing values. The number and percentage (No.) (%) of patients with missing laboratory values are the following: aPTT (n = 5, 5.8%), INR (n = 4, 4.7%), D-dimer (n = 16, 18.6%), C-reactive protein (n = 16, 18.6%), ferritin (n = 16, 18.6%), LDH (n = 21, 24.4%), ALT, (n = 2, 2.3%), and creatinine (n = 2, 2.3%). All other variables have no missing values.